Latest Strategic Shift News

Tombador Iron Limited reported a modest cash increase to AUD 10.9 million in the March quarter, driven by royalty income from its sold Tombador project, while progressing the acquisition of the Colomi Iron Project in Brazil and preparing for ASX re-listing.

Mayur Resources has completed a significant $100.1 million capital raise and secured $115 million in debt to fully fund its Central Lime Project in Papua New Guinea, while progressing construction and community agreements. The company is also rebranding to Pacific Lime and Cement Limited to reflect its new strategic focus.

Fenix Resources’ off-market takeover offer for CZR Resources has officially lapsed after failing to meet the 75% minimum acceptance threshold, leaving CZR shareholders in control of their stakes.

Atomos Limited reported a $2.3 million operating cash outflow in Q3 FY25 amid seasonal softness and tariff challenges, while announcing a leadership change and a bold expansion into new product categories beyond its core monitor-recorder business.

QMines Limited reports a 42% increase in Indicated resources at Develin Creek following maiden drilling, completes a $4 million capital raise, and moves to acquire the Mount Mackenzie gold-silver project, signaling a strategic expansion in Queensland.

Patrys Limited advances its PAT-DX3 therapy development for inflammatory diseases while navigating cash flow challenges and pursuing partnerships to sustain operations.

Farm Pride Foods reports a 15% rise in production following successful repopulation of Avian Influenza-impacted farms, alongside improved cash flow and strategic loan conversion.

Infinity Mining has expanded its exploration footprint with a new ~3,000 km² portfolio in Eastern Australia, identifying promising copper and gold targets while progressing divestment talks for its Western Australian assets.

CZR Resources has terminated its prior deal with Miracle Iron and endorsed a superior A$75 million cash offer from the Rio Tinto-led Robe River Iron Associates JV for its Robe Mesa Project. The company retains promising gold and titanium-vanadium assets while preparing for shareholder approval.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Powerhouse Ventures Limited reports a robust start to 2025, highlighted by strong fund performance, a successful capital raise, and strategic business expansion despite market volatility.